Insuline glargine [100IU/mL 3mL vial (SC)] for treatment of type 1 and type 2 diabetes mellitus
Minor Inclusion | DrugsHTA Council Recommendation (as of 16 September 2023)
As final recommendation, the HTA Council recommends the inclusion of insulin glargine [100IU/mL 3mL vial (SC)] for treatment of type 1 and type 2 diabetes mellitus in the Philippine National Formulary (PNF).
Relevant Information
- Status: With Final HTA Council Recommendation and SOH Decision
- Topic Assignment: Internal Assessment
- Policy Question: Should insulin glargine [100IU/mL 3mL vial (SC)] for treatment of type 1 and type 2 diabetes mellitus be included in the Philippine National Formulary?
- Secretary of Health Decision: Approved as of 04 December 2023
Evidence and Relevant Documents